G2A deficiency in mice promotes macrophage activation and atherosclerosis

David T Bolick1, Marcus D Skaflen, Laura E Johnson

  • 1Cardiovascular Research Center, University of Charlottesville, Charlottesville, Virginia 22908, USA.

Circulation Research
|December 25, 2008
PubMed

Insights

G2A deficiency in mice leads to increased macrophage activation and reduced apoptosis, promoting atherosclerosis development. This study highlights G2A

Area of Science:

  • Immunology
  • Cardiovascular Biology
  • Cell Biology

Background:

  • G protein-coupled receptor G2A is stress-inducible and present in atherosclerotic lesions.
  • Previous studies showed G2A deficiency increases monocyte recruitment and interactions in mouse aortas.

Purpose of the Study:

  • To investigate the specific impact of G2A deficiency on macrophage function and atherosclerosis.
  • To determine if G2A-deficient macrophages exhibit altered apoptosis, inflammatory status, and phagocytic capacity.

Main Methods:

  • Isolated peritoneal macrophages from G2A(+/+)ApoE(-/-) and G2A(-/-)ApoE(-/-) mice.
  • Assessed macrophage apoptosis, gene expression (BCL-2, BCL-xL, cFLIP, arginase-I), nuclear factor-kappaB translocation, and cytokine production (IL-12p40, TNF-alpha, IL-6).
  • Evaluated macrophage efferocytosis in vitro and analyzed atherosclerosis progression in mice fed a Western diet, including bone marrow transplantation studies.

Main Results:

  • G2A(-/-)ApoE(-/-) macrophages exhibited significantly reduced apoptosis, with increased prosurvival gene expression.
  • These macrophages displayed an M1-like proinflammatory phenotype, characterized by increased NF-kappaB activation and pro-inflammatory cytokine production.
  • G2A deficiency impaired macrophage efferocytosis and led to a 50% increase in aortic root lesion size in mice, without altering plasma lipid levels.

Conclusions:

  • G2A deficiency in macrophages promotes a pro-atherosclerotic phenotype by increasing inflammation and inhibiting apoptosis.
  • The absence of G2A leads to macrophage accumulation in the aorta, significantly contributing to atherosclerosis development.
  • Targeting G2A may offer a therapeutic strategy for managing atherosclerosis by modulating macrophage behavior.